[{"NetIncomeLoss_1_Q2_USD":-14106000.0,"InterestPaidNet_2_Q2_USD":3953000.0,"TreasuryStockCommonShares_0_Q2_shares":80085.0,"AccruedLiabilitiesCurrent_0_Q2_USD":11582000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":36080000.0,"AccruedRoyaltiesCurrent_0_Q2_USD":4688000.0,"InventoryGross_0_Q2_USD":73122000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"OperatingLeaseLiability_0_Q2_USD":351000.0,"TreasuryStockCommonValue_0_Q2_USD":3062000.0,"Liabilities_0_Q2_USD":288242000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":223000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":24261000.0,"OtherAssetsNoncurrent_0_Q2_USD":720000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":10100000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":19700000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":1688000.0,"InventoryFinishedGoods_0_Q2_USD":30267000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-14507000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-5433000.0,"IncomeTaxesPaid_2_Q2_USD":8360000.0,"InterestExpenseDebtExcludingAmortization_2_Q2_USD":4690000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_2_Q2_USD":337000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":337000.0,"InventoryValuationReserves_0_Q2_USD":5488000.0,"ResearchAndDevelopmentInProcess_2_Q2_USD":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":1700000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":1700000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":18820000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":36407000.0,"LongTermDebtCurrent_0_Q2_USD":15182000.0,"AssetsCurrent_0_Q2_USD":191799000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":56000.0,"InterestRateDerivativeLiabilitiesAtFairValue_0_Q2_USD":9040000.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":-2531000.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":-4985000.0,"GoodwillImpairmentLoss_2_Q2_USD":0.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-22687000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q2_USD":5001000.0,"InterestExpenseDebtExcludingAmortization_1_Q2_USD":2386000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-8016000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":-14020000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-582000.0,"PrepaidExpenseCurrent_0_Q2_USD":4881000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":12085000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":12045000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q2_USD":36828000.0,"EarningsPerShareBasic_1_Q2_USD":-1.17,"EarningsPerShareBasic_2_Q2_USD":-1.16,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":186369000.0,"IncreaseDecreaseInPrepaidExpense_2_Q2_USD":-1202000.0,"InventoryRawMaterials_0_Q2_USD":38877000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":377000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":2805000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":5773000.0,"RetailRelatedInventoryPackagingAndOtherSupplies_0_Q2_USD":3347000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":70000.0,"CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_1_Q2_USD":22314000.0,"CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_2_Q2_USD":42299000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-67000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-14106000.0,"AccountsReceivableNetCurrent_0_Q2_USD":92648000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-4045000.0,"IncreaseDecreaseInInventories_2_Q2_USD":-2823000.0,"CostsAndExpenses_1_Q2_USD":64178000.0,"CostsAndExpenses_2_Q2_USD":115654000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":18173000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":0.223,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.224,"DepreciationDepletionAndAmortization_1_Q2_USD":11324000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":22222000.0,"InterestCostsCapitalizedAdjustment_1_Q2_USD":31000.0,"InterestCostsCapitalizedAdjustment_2_Q2_USD":57000.0,"TreasuryStockValueAcquiredCostMethod_2_Q2_USD":816000.0,"TreasuryStockValueAcquiredCostMethod_1_Q2_USD":468000.0,"ProceedsFromLinesOfCredit_2_Q2_USD":24000000.0,"RepaymentsOfLinesOfCredit_2_Q2_USD":0.0,"DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_2_Q2_USD":81000.0,"CommonStockValue_0_Q2_USD":1000.0,"NumberOfReportableSegments_2_Q2_segment":1.0,"IncomeTaxExpenseBenefit_2_Q2_USD":-4055000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_1_Q2_USD":1000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":82000.0,"GainLossRelatedToLitigationSettlement_1_Q2_USD":-8400000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":127000.0,"InventoryWorkInProcess_0_Q2_USD":631000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":12085000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":12045000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":20909000.0,"ValuationAllowancesAndReservesBalance_0_Q2_USD":92130000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":2844000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":4713000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-18151000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-18075000.0,"Goodwill_0_Q2_USD":3580000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":20002000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":33103000.0,"AmortizationOfFinancingCosts_1_Q2_USD":176000.0,"AmortizationOfFinancingCosts_2_Q2_USD":352000.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":100000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q2_USD":100000.0,"LiabilitiesCurrent_0_Q2_USD":89454000.0,"ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_2_Q2_USD":10300000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":16395000.0,"PaymentsOfDebtIssuanceCosts_2_Q2_USD":141000.0,"NetIncomeLoss_2_Q2_USD":-14020000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":40334000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":119000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":180199000.0,"PaymentsToAcquireIntangibleAssets_2_Q2_USD":21057000.0,"AdditionalPaidInCapital_0_Q2_USD":219403000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q2_USD":-14106000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_2_Q2_USD":-14020000.0,"RepaymentsOfOtherLongTermDebt_2_Q2_USD":5206000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":180199000.0,"InterestExpenseDebt_1_Q2_USD":2531000.0,"InterestExpenseDebt_2_Q2_USD":4985000.0,"LongTermDebtNoncurrent_0_Q2_USD":189525000.0,"DeferredIncomeTaxesAndTaxCredits_2_Q2_USD":-6676000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":336000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":29262000.0,"AccountsPayableCurrent_0_Q2_USD":12977000.0,"GainLossRelatedToLitigationSettlement_2_Q2_USD":-8400000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":29754000.0,"EarningsPerShareDiluted_2_Q2_USD":-1.16,"PreferredStockValue_0_Q2_USD":null,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":366568000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":62000.0,"InventoryNet_0_Q2_USD":67634000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_2_Q2_USD":6004000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_1_Q2_USD":-401000.0,"OperatingIncomeLoss_1_Q2_USD":-15553000.0,"OperatingIncomeLoss_2_Q2_USD":-12508000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":48625000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":103146000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":26000.0,"DeferredIncomeTaxAssetsNet_0_Q2_USD":58526000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"ShareBasedCompensation_2_Q2_USD":4713000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-401000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":6004000.0,"Assets_0_Q2_USD":480159000.0,"OperatingLeaseCost_2_Q2_USD":92000.0,"EarningsPerShareDiluted_1_Q2_USD":-1.17,"OperatingLeaseCost_1_Q2_USD":43000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":4319000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-3145000.0,"LeaseCost_1_Q2_USD":56000.0,"LeaseCost_2_Q2_USD":113000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-18992000.0,"VariableLeaseCost_1_Q2_USD":13000.0,"VariableLeaseCost_2_Q2_USD":21000.0,"AmortizationOfFinancingCostsAndDiscounts_2_Q2_USD":1141000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":1630000.0,"IncreaseDecreaseInIncomeTaxes_2_Q2_USD":-6281000.0,"StockholdersEquity_0_Q2_USD":191917000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":9263000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":20117000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":128000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":60336000.0,"ImpairmentOfIntangibleAssetsFinitelived_2_Q2_USD":0.0,"DeferredTaxAssetsValuationAllowance_0_Q2_USD":300000.0,"PreferredStockSharesAuthorized_0_Q2_shares":1666667.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":480159000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_2_Q2_USD":1000.0,"Ticker":"ANIP","CIK":"1023024","name":"ANI PHARMACEUTICALS INC","OfficialName":"ANI Pharmaceuticals Inc.","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"569805985.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20210806"}]